TSHA - Taysha Gene Therapies, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$11.50
DETAILS
HIGH:
$13.00
LOW:
$11.00
MEDIAN:
$11.00
CONSENSUS:
$11.50
UPSIDE:
109.47%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Revenue | |||||||
| Revenue | 9.8 | 8.3 | 15.5 | 2.5 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 2.5 | 0 | 0.0 | 0 |
| Gross Profit | 9.8 | 8.3 | 15.5 | 0.0 | 0 | (0.0) | 0 |
| Operating Expenses | |||||||
| R&D Expenses | 86.4 | 66.0 | 56.8 | 91.2 | 131.9 | 31.9 | 1.0 |
| SG&A Expenses | 33.9 | 29.0 | 30.0 | 34.9 | 41.3 | 11.1 | 0.1 |
| Other Expenses | 0 | 4.8 | 1.1 | 0 | 0 | 0 | 0 |
| Operating Expenses | 120.3 | 99.8 | 87.9 | 126.0 | 173.3 | 43.0 | 1.1 |
| Operating Income | |||||||
| Operating Income | (110.5) | (91.5) | (72.4) | (126.0) | (173.3) | (43.0) | (1.1) |
| Interest Expense | 0.1 | 0.1 | 5.0 | 3.8 | 1.4 | 0.0 | 0 |
| Interest Income | 9.2 | 6.9 | 3.6 | 0.2 | 0.2 | 0.0 | 0 |
| Profitability | |||||||
| EBITDA | (107.8) | (88.0) | (105.2) | (159.7) | (172.6) | (60.0) | 0 |
| EBIT | (108.9) | (89.2) | (106.6) | (162.2) | (173.1) | (60.0) | (4.5) |
| Income Before Tax | (109.0) | (89.3) | (111.6) | (166.0) | (174.5) | (60.0) | (1.1) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | (109.0) | (89.3) | (111.6) | (166.0) | (174.5) | (43) | (1.1) |
| Per Share Data | |||||||
| EPS (Basic) | -0.34 | -0.36 | -0.96 | -3.78 | -4.64 | -3.40 | -0.03 |
| EPS (Diluted) | -0.34 | -0.36 | -0.96 | -3.78 | -4.64 | -3.40 | -0.03 |
| Shares Outstanding | 319.7 | 250.1 | 116.1 | 44.0 | 37.7 | 17.7 | 37.0 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Current Assets | |||||||
| Cash & Cash Equivalents | 319.8 | 139.0 | 143.9 | 87.9 | 149.1 | 251.3 | 0 |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 4.9 | 0.9 | 3.4 | 1.2 | 6.6 | 0.3 | 0.0 |
| Total Current Assets | 324.6 | 142.1 | 149.9 | 96.4 | 159.6 | 257.9 | 0.0 |
| Non-Current Assets | |||||||
| Property, Plant & Equipment | 16.2 | 15.9 | 20.4 | 25.9 | 50.6 | 0.3 | 0 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 2.3 | 0 | 0 | 0 | 2.6 | 0 | 0 |
| Other Non-Current Assets | 0.2 | 2.4 | 2.5 | 4.0 | 1.1 | 0.7 | 0.0 |
| Total Non-Current Assets | 18.7 | 18.2 | 22.9 | 29.9 | 54.4 | 1.0 | 0.0 |
| Total Assets | 343.3 | 160.4 | 172.7 | 126.3 | 214.0 | 258.9 | 0.0 |
| Current Liabilities | |||||||
| Account Payables | 6.3 | 3.6 | 6.4 | 10.9 | 21.8 | 2.0 | 0 |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 9.8 | 18.1 | 33.6 | 0 | 0 | 0 |
| Other Current Liabilities | 10.9 | 6.4 | 5.0 | 4.6 | 4.1 | 1.9 | 0.0 |
| Total Current Liabilities | 26.6 | 26.2 | 36.8 | 62.8 | 51.7 | 7.1 | 0.1 |
| Non-Current Liabilities | |||||||
| Long-Term Debt | 18.2 | 43.9 | 40.5 | 38.0 | 37.2 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 51.7 | 1.3 | 1.6 | 4.1 | 3.7 | 0.5 | 0 |
| Total Non-Current Liabilities | 69.8 | 62.6 | 61.0 | 62.5 | 66.8 | 0.5 | 0 |
| Total Liabilities | 96.4 | 88.8 | 97.8 | 125.3 | 118.6 | 7.6 | 0.1 |
| Stockholders' Equity | |||||||
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0 | 0 | 0 |
| Retained Earnings | (711.3) | (602.3) | (513.0) | (401.4) | (235.6) | (61.1) | (1.1) |
| Accumulated Other Comprehensive Income | (0.2) | (4.0) | 0 | 0 | 0 | 0 | 0 |
| Total Stockholders' Equity | 246.9 | 71.5 | 74.9 | 0.9 | 95.4 | 251.3 | (0.1) |
| Total Liabilities & Equity | 343.3 | 160.4 | 172.7 | 126.3 | 214.0 | 258.9 | 0.0 |
| Debt Metrics | |||||||
| Total Debt | 18.2 | 63.2 | 61.1 | 59.9 | 63.1 | 0 | 0 |
| Net Debt | (301.6) | (75.9) | (82.8) | (28.0) | (86.0) | (251.3) | 0 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | (109.0) | (89.3) | (111.6) | (166.0) | (174.5) | (60.0) | (1.1) |
| Depreciation & Amortization | 1.1 | 1.2 | 1.4 | 1.2 | 0.5 | 0.0 | 0 |
| Stock-Based Compensation | 13.3 | 13.1 | 7.9 | 18.0 | 18.2 | 3.4 | 0 |
| Change in Working Capital | (5.4) | (12.5) | (18.0) | 18.5 | 28.7 | (0.1) | 0.5 |
| Other Non-Cash Items | 6.8 | 6.2 | 47.3 | 39.9 | 10.1 | 26.0 | 0.7 |
| Operating Cash Flow | (93.1) | (81.2) | (73.0) | (88.4) | (117.0) | (30.7) | 0.1 |
| Investing Activities | |||||||
| Capital Expenditure | (0.7) | (0.4) | (7.4) | (24.9) | (21.6) | (9.1) | 0 |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales/Maturities of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0.1 | 0.0 | (3.5) | (0.1) | 0 | (9) | 0 |
| Investing Cash Flow | (0.6) | (0.4) | (7.4) | (24.9) | (21.6) | (9.1) | 0 |
| Financing Activities | |||||||
| Net Debt Issuance | 9.2 | 0 | (3.5) | 0 | 40.0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (0.3) | (0.1) | (0.9) | (1.1) | (0.5) | 0 | 0 |
| Financing Cash Flow | 274.6 | 76.7 | 136.4 | 52.1 | 39.1 | 291.1 | 0 |
| Cash Position | |||||||
| Net Change in Cash | 180.9 | (4.9) | 56.0 | (61.2) | (99.5) | 251.3 | 0.1 |
| Cash at Beginning | 141.6 | 146.5 | 90.5 | 151.7 | 251.3 | 0 | 0 |
| Cash at End | 322.5 | 141.6 | 146.5 | 90.5 | 151.7 | 251.3 | 0.1 |
| Free Cash Flow | (93.8) | (81.6) | (80.4) | (113.3) | (138.6) | (39.8) | 0.1 |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 9.8 | 8.3 | 15.5 | 2.5 | 0 | 0 | 0 |
| Gross Profit | 9.8 | 8.3 | 15.5 | 0.0 | 0 | (0.0) | 0 |
| Operating Income | (110.5) | (91.5) | (72.4) | (126.0) | (173.3) | (43.0) | (1.1) |
| Net Income | (109.0) | (89.3) | (111.6) | (166.0) | (174.5) | (43) | (1.1) |
| EPS (Diluted) | -0.34 | -0.36 | -0.96 | -3.78 | -4.64 | -3.40 | -0.03 |
| Balance Sheet | |||||||
| Cash & Equivalents | 319.8 | 139.0 | 143.9 | 87.9 | 149.1 | 251.3 | 0 |
| Total Assets | 343.3 | 160.4 | 172.7 | 126.3 | 214.0 | 258.9 | 0.0 |
| Total Debt | 18.2 | 63.2 | 61.1 | 59.9 | 63.1 | 0 | 0 |
| Stockholders' Equity | 246.9 | 71.5 | 74.9 | 0.9 | 95.4 | 251.3 | (0.1) |
| Cash Flow | |||||||
| Operating Cash Flow | (93.1) | (81.2) | (73.0) | (88.4) | (117.0) | (30.7) | 0.1 |
| Capital Expenditure | (0.7) | (0.4) | (7.4) | (24.9) | (21.6) | (9.1) | 0 |
| Free Cash Flow | (93.8) | (81.6) | (80.4) | (113.3) | (138.6) | (39.8) | 0.1 |